Press release
Bacterial Cell Culture Market Size (USD 5.2 billion by 2031) Pioneering Growth to Fulfill Healthcare Requirements
Bacterial culture is a process of growing bacteria and to duplicate them in a culture media, in a controlled laboratory environment. Bacterial cell culture technology has different applications such as food testing, water testing, biopharmaceuticals, and disease diagnosis. There has been witnessed a rise in the utilization of the technique by research laboratories, biopharmaceutical companies, diagnostic centers, and academic institutions which is resulting into increased revenue-generation of the bacterial cell culture market.Allied Market Research published a report, titled, "Bacterial Cell Culture Market by Product Type (Media, Reagents, Sera), by Application (Disease Diagnosis, Food Testing, Water Testing, Others), by End user (Diagnostic Centers, Food Industry, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031". According to the report, the global Bacterial Cell Culture Market Size was Valued at USD 2.8 billion in 2021 and is Projected to surpass around USD 5.2 billion by 2031, registering revenue CAGR of 6.3% from 2021 to 2030.
The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.
๐๐๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐๐ซ๐๐ฉ๐ก๐ฌ ๐๐ง๐ ๐ ๐ข๐ ๐ฎ๐ซ๐๐ฌ ๐๐๐ซ๐: https://www.alliedmarketresearch.com/request-sample/16010
๐๐ก๐๐ญ ๐๐ซ๐ ๐ญ๐ก๐ ๐๐๐๐๐ง๐ญ ๐๐ซ๐๐ง๐๐ฌ ๐ข๐ง ๐ญ๐ก๐ ๐๐๐๐ญ๐๐ซ๐ข๐๐ฅ ๐๐๐ฅ๐ฅ ๐๐ฎ๐ฅ๐ญ๐ฎ๐ซ๐ ๐๐๐ซ๐ค๐๐ญ?
The increase in adoption of bacterial cell culture for food testing, rise in usage of bacterial cell culture in animal feed, and increase in adoption of bacterial cell culture techniques in biopharmaceuticals drive the growth of the global bacterial cell culture market. However, lack of skilled professionals for handling this advanced healthcare infrastructure as well as the high investment associated with the research and development restrict the market growth. Moreover, increase in healthcare expenditure and technological advancements in the biotechnology field present new opportunities in the coming years.
๐๐จ๐ฉ ๐๐๐๐ญ๐๐ซ๐ข๐๐ฅ ๐๐๐ฅ๐ฅ ๐๐ฎ๐ฅ๐ญ๐ฎ๐ซ๐ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ
โข Thermo Fisher Scientific, Inc.
โข ScienCell Research Laboratories, Inc.
โข Bio-Rad Laboratories, Inc.
โข Eiken Chemical Co, Ltd.
โข EMD (Merck) Millipore
โข Hi-Media Laboratories Pvt. Ltd.
โข Neogen Corporation
โข BioMรฉrieux S.A.
โข Biokel Scientific
โข Danaher Corporation
๐๐๐๐ญ๐๐ซ๐ข๐๐ฅ ๐๐๐ฅ๐ฅ ๐๐ฎ๐ฅ๐ญ๐ฎ๐ซ๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง: -
Based on product type, the media segment held the highest market share in 2021, accounting for nearly half of the global bacterial cell culture market, and is estimated to maintain its leadership status throughout the forecast period. In addition, the same segment is projected to manifest the highest CAGR of 7.3% from 2022 to 2031, owing to the advancement and development in the cell culture media which offers various advantages and high purity cultures.
Based on application, the food testing segment held the highest market share in 2021, accounting for nearly one-third of the global bacterial cell culture market. This is due to the strict regulations put forth by the government regarding food testing and usage of bacterial cell culture in food testing. However, the disease diagnosis segment is projected to manifest the highest CAGR of 8.2% from 2022 to 2031, and is estimated to maintain its leadership status in terms of revenue in 2031. This is owing to the wide application of bacterial cell culture in the diagnosis of various diseases.
Based on end user, the others segment accounted for the largest share in 2021, contributing to nearly half of the global bacterial cell culture market, and is projected to maintain its lead position during the forecast period. The same segment is expected to portray the largest CAGR of 7.0% from 2022 to 2031, attributed to the rise in research and development activities.
Based on region, North America held the highest market share in terms of revenue in 2021, accounting for more than two-fifths of the global bacterial cell culture market, and is likely to dominate the market during the forecast period. This is owing to the presence of key players, rising government initiatives, well-developed healthcare infrastructure, and rising awareness about the innovations in the healthcare sector in the region. However, the Asia-Pacific region is expected to witness the fastest CAGR of 8.2% from 2022 to 2031, due to the increase in the need for better healthcare facilities and huge investments by public and private market players in this region.
Purchase the Report: https://www.alliedmarketresearch.com/purchase-enquiry/16010
Our Market Research Solution Provides You Answer to Below Mentioned Question:
โข Which are the driving factors responsible for the growth of market?
โข Which are the roadblock factors of this market?
โข What are the new opportunities, by which market will grow in coming years?
โข What are the trends of this market?
โข Which are main factors responsible for new product launch?
โข How big is the global & regional market in terms of revenue, sales and production?
โข How far will the market grow in forecast period in terms of revenue, sales and production?
โข Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
โข How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
โข Which region has more opportunities?
By Region Outlook
โข North America
(U.S., Canada, Mexico)
โข Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
โข Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
โข LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Contact Details:
David Correa
USA/Canada (Toll-Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bacterial Cell Culture Market Size (USD 5.2 billion by 2031) Pioneering Growth to Fulfill Healthcare Requirements here
News-ID: 3317107 • Views: โฆ
More Releases from Allied Market Research (AMR)
Revolutionizing Healthcare: Medical Cannabis Market Projected to Reach USD 53.88 โฆ
Allied Market Research published a report, titled, "Medical Cannabis Market by Product Type (Buds/Marijuana Flower and Cannabis Extracts), Application (Chronic Pain, Mental Disorders, Cancer, and Others), and End User (Pharmaceutical and Research & Development Centers): Global Opportunity Analysis and Industry Forecast, 2021-2030." According to the report, the global medical cannabis industry generated USD 6.82 billion in 2020 and is expected to reach USD 53.88 billion by 2030, witnessing a CAGRโฆ
Healthcare Fraud Detection Market Updates : Projected to Attain USD 3.6 Billion โฆ
According to a new report published by Allied Market Research, titled, "Healthcare Fraud Detection Market," the healthcare fraud detection market was valued at $1.1 billion in 2021, and is estimated to reach $3.6 billion by 2031, growing at a CAGR of 12.6% from 2022 to 2031.
Healthcare or medical fraud involves making false statements or misrepresentations about medical bills, healthcare funds, or the nature of medical treatments or services provided, leadingโฆ
Technical Textile Market Size, Growth Drivers and Strategic Analysis Through 203 โฆ
According to a recent report published by Allied Market Research, titled "Technical Textile Market by Material, Process, and End-Use Application: Global Opportunity Analysis and Industry Forecast, 2023-2032", the global technical textile market was valued at $191.7 billion in 2022 and is projected to reach $331.8 billion by 2032, registering a CAGR of 5.7% during the forecast period.
Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/1841
Market Growth Drivers:-
- The growth of the globalโฆ
Protective Clothing Market Outlook 2026-2033 Industry Size, Segmentation, Key Pl โฆ
Allied Market Research has published a comprehensive report titled "Protective Clothing Market by Material Type, Application, and End-use Industry: Global Opportunity Analysis and Industry Forecast, 2024-2033." According to the study, the global protective clothing market was valued at $10.3 billion in 2023 and is projected to reach $18.6 billion by 2033, registering a CAGR of 6.1% during the forecast period.
Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/371
Market Growth Drivers and Challenges:
-โฆ
More Releases for Bacterial
Prominent Bacterial Conjunctivitis Market Trend for 2025: Innovative Eye Drops T โฆ
What Are the Projected Growth and Market Size Trends for the Bacterial Conjunctivitis Market?
The bacterial conjunctivitis market has grown steadily, projected to expand from $4.52 billion in 2024 to $4.76 billion in 2025, at a CAGR of 5.3%. Growth factors include rising bacterial infection cases, improved diagnostics, patient education programs, stringent regulatory frameworks, and physician training.
The bacterial conjunctivitis market is projected to grow steadily, reaching $5.54 billion by 2029 atโฆ
Community-Acquired Bacterial Pneumonia Market
DelveInsight's "Community-Acquired Bacterial Pneumonia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Community-Acquired Bacterial Pneumonia, historical and forecasted epidemiology as well as the Community-Acquired Bacterial Pneumonia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Community-Acquired Bacterial Pneumonia market report provides current treatment practices, emerging drugs, Community-Acquired Bacterial Pneumonia market share of the individual therapies, and currentโฆ
Bacterial Conjunctivitis Drugs Market Report 2018: Segmentation by Disease Type โฆ
Global Bacterial Conjunctivitis Drugs market research report provides company profile for Pfizer Inc., Novartis AG, F. Hoffmann-La Roche, Bayer Healthcare, Valeant Pharmaceutical International Inc., Perrigo Company Plc, Akorn Inc., Santen Pharmaceutical Co. Ltd., Allergan Plc. and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growthโฆ
Bacterial Conjunctivitis Drugs Market: Rising Incidence of Ophthalmic Bacterial โฆ
The U.S. market for bacterial conjunctivitis drugs has been declining sharply over the last few years. Analysts project the trend to continue in the coming years. In 2013, the marketโs opportunity was valued at US$473.3 mn, which is likely to reduce to US$439.8 mn by 2024. In the coming years, the market will have to experience a patent cliff as the top U.S. brands of bacterial conjunctivitis drugs, such asโฆ
Bacterial Conjunctivitis Drugs Market Driven by Rising Incidence of Ophthalmic B โฆ
The U.S. market for bacterial conjunctivitis drugs is extremely fragmented, leading to commensurate competition among players. The entry barriers faced by new players despite having good research and development capabilities, is lack of capital, Transparency Market Research (TMR) states in its new report on the U.S. market for bacterial conjunctivitis drugs. R&D involves huge costs and this limits the production. Mergers and acquisitions and other forms of strategic alliances canโฆ
Bacterial Conjunctivitis Drugs Market Driven by Rising Incidence of Ophthalmic B โฆ
The U.S. market for bacterial conjunctivitis drugs has been declining sharply over the last few years. Analysts project the trend to continue in the coming years. In 2013, the marketโs opportunity was valued at US$473.3 mn, which is likely to reduce to US$439.8 mn by 2024. In the coming years, the market will have to experience a patent cliff as the top U.S. brands of bacterial conjunctivitis drugs, such asโฆ
